Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
22
BHST Quote, Financials, Valuation and Earnings
Last price:
$5.3000
Seasonality move
:
28.34%
Day range:
$5.0500 - $5.3500
52-week range:
$4.7237 - $12.8000
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.75x
P/B ratio:
15.20x
Volume:
29.5K
Avg. volume:
64.5K
1-year change:
-16.02%
Market cap:
$117.6M
Revenue:
$25.2M
EPS (TTM):
-$0.69
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BHST
BioHarvest Sciences, Inc.
|
$9.2M | -$0.10 | 25.84% | -43.34% | $13.6667 |
|
ABVE
Above Food Ingredients, Inc.
|
-- | -- | -- | -- | -- |
|
ACU
Acme United Corp.
|
$47.3M | -- | 2.89% | -- | $50.00 |
|
BRLS
Borealis Foods, Inc.
|
-- | -- | -- | -- | -- |
|
DTEAF
DAVIDsTEA, Inc.
|
-- | -- | -- | -- | -- |
|
LSF
Laird Superfood, Inc.
|
$13.1M | -- | 13.23% | -- | $7.67 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BHST
BioHarvest Sciences, Inc.
|
$5.1900 | $13.6667 | $117.6M | -- | $0.00 | 0% | 2.75x |
|
ABVE
Above Food Ingredients, Inc.
|
$1.63 | -- | $83.4M | -- | $0.00 | 0% | -- |
|
ACU
Acme United Corp.
|
$40.31 | $50.00 | $153.4M | 16.57x | $0.16 | 1.54% | 0.85x |
|
BRLS
Borealis Foods, Inc.
|
$2.00 | -- | $42.9M | -- | $0.00 | 0% | 1.53x |
|
DTEAF
DAVIDsTEA, Inc.
|
$0.68 | -- | $18.3M | 1,700.00x | $0.00 | 0% | 0.43x |
|
LSF
Laird Superfood, Inc.
|
$2.22 | $7.67 | $23.7M | -- | $0.00 | 0% | 0.48x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BHST
BioHarvest Sciences, Inc.
|
71.95% | -0.539 | 10.75% | 0.94x |
|
ABVE
Above Food Ingredients, Inc.
|
145.3% | -5.309 | -- | 0.20x |
|
ACU
Acme United Corp.
|
23.51% | -0.208 | 22.7% | 1.61x |
|
BRLS
Borealis Foods, Inc.
|
159.75% | -1.405 | 59.9% | 0.05x |
|
DTEAF
DAVIDsTEA, Inc.
|
41.98% | 3.807 | 51.21% | 0.55x |
|
LSF
Laird Superfood, Inc.
|
1.38% | 1.467 | 0.3% | 1.22x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BHST
BioHarvest Sciences, Inc.
|
$5.6M | -$920K | -60.26% | -733.31% | -10.15% | -$2.5M |
|
ABVE
Above Food Ingredients, Inc.
|
-- | -- | -- | -- | -- | $2.8M |
|
ACU
Acme United Corp.
|
$19.2M | $3M | 6.9% | 9.09% | 6.13% | $301K |
|
BRLS
Borealis Foods, Inc.
|
$1M | -$1.9M | -65.51% | -34641.89% | -27.1% | -$122.9K |
|
DTEAF
DAVIDsTEA, Inc.
|
$3.8M | -$147K | 0.21% | 0.36% | -1.62% | -$693.1K |
|
LSF
Laird Superfood, Inc.
|
$4.7M | -$995.6K | -14.14% | -14.38% | -7.72% | $1.3M |
BioHarvest Sciences, Inc. vs. Competitors
-
Which has Higher Returns BHST or ABVE?
Above Food Ingredients, Inc. has a net margin of -27.72% compared to BioHarvest Sciences, Inc.'s net margin of --. BioHarvest Sciences, Inc.'s return on equity of -733.31% beat Above Food Ingredients, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BHSTBioHarvest Sciences, Inc.61.43% -$0.14 $27.6M ABVEAbove Food Ingredients, Inc.-- -- $38.8M -
What do Analysts Say About BHST or ABVE?
BioHarvest Sciences, Inc. has a consensus price target of $13.6667, signalling upside risk potential of 163.33%. On the other hand Above Food Ingredients, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that BioHarvest Sciences, Inc. has higher upside potential than Above Food Ingredients, Inc., analysts believe BioHarvest Sciences, Inc. is more attractive than Above Food Ingredients, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BHSTBioHarvest Sciences, Inc.2 0 0 ABVEAbove Food Ingredients, Inc.0 0 0 -
Is BHST or ABVE More Risky?
BioHarvest Sciences, Inc. has a beta of 1.097, which suggesting that the stock is 9.673% more volatile than S&P 500. In comparison Above Food Ingredients, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BHST or ABVE?
BioHarvest Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Above Food Ingredients, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BioHarvest Sciences, Inc. pays -- of its earnings as a dividend. Above Food Ingredients, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BHST or ABVE?
BioHarvest Sciences, Inc. quarterly revenues are $9.1M, which are larger than Above Food Ingredients, Inc. quarterly revenues of --. BioHarvest Sciences, Inc.'s net income of -$2.5M is higher than Above Food Ingredients, Inc.'s net income of --. Notably, BioHarvest Sciences, Inc.'s price-to-earnings ratio is -- while Above Food Ingredients, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BioHarvest Sciences, Inc. is 2.75x versus -- for Above Food Ingredients, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BHSTBioHarvest Sciences, Inc.2.75x -- $9.1M -$2.5M ABVEAbove Food Ingredients, Inc.-- -- -- --
-
Which has Higher Returns BHST or ACU?
Acme United Corp. has a net margin of -27.72% compared to BioHarvest Sciences, Inc.'s net margin of 3.88%. BioHarvest Sciences, Inc.'s return on equity of -733.31% beat Acme United Corp.'s return on equity of 9.09%.
Company Gross Margin Earnings Per Share Invested Capital BHSTBioHarvest Sciences, Inc.61.43% -$0.14 $27.6M ACUAcme United Corp.39.12% $0.46 $151.4M -
What do Analysts Say About BHST or ACU?
BioHarvest Sciences, Inc. has a consensus price target of $13.6667, signalling upside risk potential of 163.33%. On the other hand Acme United Corp. has an analysts' consensus of $50.00 which suggests that it could grow by 24.04%. Given that BioHarvest Sciences, Inc. has higher upside potential than Acme United Corp., analysts believe BioHarvest Sciences, Inc. is more attractive than Acme United Corp..
Company Buy Ratings Hold Ratings Sell Ratings BHSTBioHarvest Sciences, Inc.2 0 0 ACUAcme United Corp.1 0 0 -
Is BHST or ACU More Risky?
BioHarvest Sciences, Inc. has a beta of 1.097, which suggesting that the stock is 9.673% more volatile than S&P 500. In comparison Acme United Corp. has a beta of 0.730, suggesting its less volatile than the S&P 500 by 26.959%.
-
Which is a Better Dividend Stock BHST or ACU?
BioHarvest Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Acme United Corp. offers a yield of 1.54% to investors and pays a quarterly dividend of $0.16 per share. BioHarvest Sciences, Inc. pays -- of its earnings as a dividend. Acme United Corp. pays out 24.54% of its earnings as a dividend. Acme United Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios BHST or ACU?
BioHarvest Sciences, Inc. quarterly revenues are $9.1M, which are smaller than Acme United Corp. quarterly revenues of $49.1M. BioHarvest Sciences, Inc.'s net income of -$2.5M is lower than Acme United Corp.'s net income of $1.9M. Notably, BioHarvest Sciences, Inc.'s price-to-earnings ratio is -- while Acme United Corp.'s PE ratio is 16.57x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BioHarvest Sciences, Inc. is 2.75x versus 0.85x for Acme United Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BHSTBioHarvest Sciences, Inc.2.75x -- $9.1M -$2.5M ACUAcme United Corp.0.85x 16.57x $49.1M $1.9M
-
Which has Higher Returns BHST or BRLS?
Borealis Foods, Inc. has a net margin of -27.72% compared to BioHarvest Sciences, Inc.'s net margin of -53.22%. BioHarvest Sciences, Inc.'s return on equity of -733.31% beat Borealis Foods, Inc.'s return on equity of -34641.89%.
Company Gross Margin Earnings Per Share Invested Capital BHSTBioHarvest Sciences, Inc.61.43% -$0.14 $27.6M BRLSBorealis Foods, Inc.14.65% -$0.18 $21.7M -
What do Analysts Say About BHST or BRLS?
BioHarvest Sciences, Inc. has a consensus price target of $13.6667, signalling upside risk potential of 163.33%. On the other hand Borealis Foods, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that BioHarvest Sciences, Inc. has higher upside potential than Borealis Foods, Inc., analysts believe BioHarvest Sciences, Inc. is more attractive than Borealis Foods, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BHSTBioHarvest Sciences, Inc.2 0 0 BRLSBorealis Foods, Inc.0 0 0 -
Is BHST or BRLS More Risky?
BioHarvest Sciences, Inc. has a beta of 1.097, which suggesting that the stock is 9.673% more volatile than S&P 500. In comparison Borealis Foods, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BHST or BRLS?
BioHarvest Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Borealis Foods, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BioHarvest Sciences, Inc. pays -- of its earnings as a dividend. Borealis Foods, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BHST or BRLS?
BioHarvest Sciences, Inc. quarterly revenues are $9.1M, which are larger than Borealis Foods, Inc. quarterly revenues of $7.1M. BioHarvest Sciences, Inc.'s net income of -$2.5M is higher than Borealis Foods, Inc.'s net income of -$3.8M. Notably, BioHarvest Sciences, Inc.'s price-to-earnings ratio is -- while Borealis Foods, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BioHarvest Sciences, Inc. is 2.75x versus 1.53x for Borealis Foods, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BHSTBioHarvest Sciences, Inc.2.75x -- $9.1M -$2.5M BRLSBorealis Foods, Inc.1.53x -- $7.1M -$3.8M
-
Which has Higher Returns BHST or DTEAF?
DAVIDsTEA, Inc. has a net margin of -27.72% compared to BioHarvest Sciences, Inc.'s net margin of -5.08%. BioHarvest Sciences, Inc.'s return on equity of -733.31% beat DAVIDsTEA, Inc.'s return on equity of 0.36%.
Company Gross Margin Earnings Per Share Invested Capital BHSTBioHarvest Sciences, Inc.61.43% -$0.14 $27.6M DTEAFDAVIDsTEA, Inc.42.11% -$0.02 $20M -
What do Analysts Say About BHST or DTEAF?
BioHarvest Sciences, Inc. has a consensus price target of $13.6667, signalling upside risk potential of 163.33%. On the other hand DAVIDsTEA, Inc. has an analysts' consensus of -- which suggests that it could grow by 414.61%. Given that DAVIDsTEA, Inc. has higher upside potential than BioHarvest Sciences, Inc., analysts believe DAVIDsTEA, Inc. is more attractive than BioHarvest Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BHSTBioHarvest Sciences, Inc.2 0 0 DTEAFDAVIDsTEA, Inc.0 0 0 -
Is BHST or DTEAF More Risky?
BioHarvest Sciences, Inc. has a beta of 1.097, which suggesting that the stock is 9.673% more volatile than S&P 500. In comparison DAVIDsTEA, Inc. has a beta of 1.108, suggesting its more volatile than the S&P 500 by 10.805%.
-
Which is a Better Dividend Stock BHST or DTEAF?
BioHarvest Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DAVIDsTEA, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BioHarvest Sciences, Inc. pays -- of its earnings as a dividend. DAVIDsTEA, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BHST or DTEAF?
BioHarvest Sciences, Inc. quarterly revenues are $9.1M, which are smaller than DAVIDsTEA, Inc. quarterly revenues of $9.1M. BioHarvest Sciences, Inc.'s net income of -$2.5M is lower than DAVIDsTEA, Inc.'s net income of -$461.9K. Notably, BioHarvest Sciences, Inc.'s price-to-earnings ratio is -- while DAVIDsTEA, Inc.'s PE ratio is 1,700.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BioHarvest Sciences, Inc. is 2.75x versus 0.43x for DAVIDsTEA, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BHSTBioHarvest Sciences, Inc.2.75x -- $9.1M -$2.5M DTEAFDAVIDsTEA, Inc.0.43x 1,700.00x $9.1M -$461.9K
-
Which has Higher Returns BHST or LSF?
Laird Superfood, Inc. has a net margin of -27.72% compared to BioHarvest Sciences, Inc.'s net margin of -7.56%. BioHarvest Sciences, Inc.'s return on equity of -733.31% beat Laird Superfood, Inc.'s return on equity of -14.38%.
Company Gross Margin Earnings Per Share Invested Capital BHSTBioHarvest Sciences, Inc.61.43% -$0.14 $27.6M LSFLaird Superfood, Inc.36.19% -$0.09 $13M -
What do Analysts Say About BHST or LSF?
BioHarvest Sciences, Inc. has a consensus price target of $13.6667, signalling upside risk potential of 163.33%. On the other hand Laird Superfood, Inc. has an analysts' consensus of $7.67 which suggests that it could grow by 245.35%. Given that Laird Superfood, Inc. has higher upside potential than BioHarvest Sciences, Inc., analysts believe Laird Superfood, Inc. is more attractive than BioHarvest Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BHSTBioHarvest Sciences, Inc.2 0 0 LSFLaird Superfood, Inc.2 0 0 -
Is BHST or LSF More Risky?
BioHarvest Sciences, Inc. has a beta of 1.097, which suggesting that the stock is 9.673% more volatile than S&P 500. In comparison Laird Superfood, Inc. has a beta of 2.387, suggesting its more volatile than the S&P 500 by 138.679%.
-
Which is a Better Dividend Stock BHST or LSF?
BioHarvest Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Laird Superfood, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BioHarvest Sciences, Inc. pays -- of its earnings as a dividend. Laird Superfood, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BHST or LSF?
BioHarvest Sciences, Inc. quarterly revenues are $9.1M, which are smaller than Laird Superfood, Inc. quarterly revenues of $12.9M. BioHarvest Sciences, Inc.'s net income of -$2.5M is lower than Laird Superfood, Inc.'s net income of -$975.1K. Notably, BioHarvest Sciences, Inc.'s price-to-earnings ratio is -- while Laird Superfood, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BioHarvest Sciences, Inc. is 2.75x versus 0.48x for Laird Superfood, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BHSTBioHarvest Sciences, Inc.2.75x -- $9.1M -$2.5M LSFLaird Superfood, Inc.0.48x -- $12.9M -$975.1K
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 5.09% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 3.81% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 9.27% over the past day.
